NORTHWEST BIOTHERAPEUTICS
Live / Registered — Registered and renewed (as of 28 Jul 2025)
What this means for you
Registered since 07 Sept 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Sept 2024).
Record
- Serial number
- 76325495
- Registration number
- 2882249
- Mark type
- Word mark
- Filed
- 15 Oct 2001
- Published for opposition
- 20 Aug 2002
- Registered
- 07 Sept 2004
- Next maintenance due
- 07 Sept 2024
- Attorney of record
- Melissa A. Nowak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of cancer
Owner
- Northwest Biotherapeutics, Inc., Bethesda, MD, US
- Northwest Biotherapeutics, Inc., Bothel, WA, US
- Northwest Biotherapeutics, Inc., Bothel, WA, US
Prosecution history
- 28 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 28 Jul 2025 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 28 Jul 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 28 Jul 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Mar 2025 — TEAS SECTION 8 & 9 RECEIVED
- 07 Sept 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 18 Sept 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 18 Sept 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 18 Sept 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Sept 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Sept 2014 — TEAS SECTION 8 & 9 RECEIVED
- 29 Apr 2014 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Sept 2010 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 14 Sept 2010 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Aug 2010 — TEAS SECTION 8 & 15 RECEIVED